×
S&P 500   3,905.14 (+0.13%)
DOW   31,549.91 (+0.36%)
QQQ   290.85 (-0.55%)
AAPL   140.90 (-0.54%)
MSFT   261.98 (-1.10%)
META   168.66 (-0.49%)
GOOGL   2,279.08 (-1.62%)
AMZN   110.63 (-2.29%)
TSLA   731.61 (-0.43%)
NVDA   165.62 (-1.82%)
NIO   22.71 (-1.05%)
BABA   119.35 (+0.52%)
AMD   83.73 (-2.82%)
MU   59.67 (+1.51%)
CGC   3.71 (-2.11%)
T   20.99 (+1.01%)
GE   67.38 (+1.00%)
F   12.27 (+1.91%)
DIS   100.05 (+3.56%)
AMC   13.82 (-2.19%)
PFE   51.39 (-0.94%)
PYPL   75.18 (-1.00%)
NFLX   187.35 (-0.95%)
S&P 500   3,905.14 (+0.13%)
DOW   31,549.91 (+0.36%)
QQQ   290.85 (-0.55%)
AAPL   140.90 (-0.54%)
MSFT   261.98 (-1.10%)
META   168.66 (-0.49%)
GOOGL   2,279.08 (-1.62%)
AMZN   110.63 (-2.29%)
TSLA   731.61 (-0.43%)
NVDA   165.62 (-1.82%)
NIO   22.71 (-1.05%)
BABA   119.35 (+0.52%)
AMD   83.73 (-2.82%)
MU   59.67 (+1.51%)
CGC   3.71 (-2.11%)
T   20.99 (+1.01%)
GE   67.38 (+1.00%)
F   12.27 (+1.91%)
DIS   100.05 (+3.56%)
AMC   13.82 (-2.19%)
PFE   51.39 (-0.94%)
PYPL   75.18 (-1.00%)
NFLX   187.35 (-0.95%)
S&P 500   3,905.14 (+0.13%)
DOW   31,549.91 (+0.36%)
QQQ   290.85 (-0.55%)
AAPL   140.90 (-0.54%)
MSFT   261.98 (-1.10%)
META   168.66 (-0.49%)
GOOGL   2,279.08 (-1.62%)
AMZN   110.63 (-2.29%)
TSLA   731.61 (-0.43%)
NVDA   165.62 (-1.82%)
NIO   22.71 (-1.05%)
BABA   119.35 (+0.52%)
AMD   83.73 (-2.82%)
MU   59.67 (+1.51%)
CGC   3.71 (-2.11%)
T   20.99 (+1.01%)
GE   67.38 (+1.00%)
F   12.27 (+1.91%)
DIS   100.05 (+3.56%)
AMC   13.82 (-2.19%)
PFE   51.39 (-0.94%)
PYPL   75.18 (-1.00%)
NFLX   187.35 (-0.95%)
S&P 500   3,905.14 (+0.13%)
DOW   31,549.91 (+0.36%)
QQQ   290.85 (-0.55%)
AAPL   140.90 (-0.54%)
MSFT   261.98 (-1.10%)
META   168.66 (-0.49%)
GOOGL   2,279.08 (-1.62%)
AMZN   110.63 (-2.29%)
TSLA   731.61 (-0.43%)
NVDA   165.62 (-1.82%)
NIO   22.71 (-1.05%)
BABA   119.35 (+0.52%)
AMD   83.73 (-2.82%)
MU   59.67 (+1.51%)
CGC   3.71 (-2.11%)
T   20.99 (+1.01%)
GE   67.38 (+1.00%)
F   12.27 (+1.91%)
DIS   100.05 (+3.56%)
AMC   13.82 (-2.19%)
PFE   51.39 (-0.94%)
PYPL   75.18 (-1.00%)
NFLX   187.35 (-0.95%)
NASDAQ:CYRX

Cryoport Stock Forecast, Price & News

$30.08
+0.40 (+1.35%)
(As of 06/28/2022 10:34 AM ET)
Add
Compare
Today's Range
$29.45
$30.21
50-Day Range
$20.38
$31.11
52-Week Range
$19.82
$86.30
Volume
2,936 shs
Average Volume
479,275 shs
Market Capitalization
$1.49 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$61.17
30 days | 90 days | 365 days | Advanced Chart

Receive CYRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter.

CYRX Stock Forecast (MarketRank)

Overall MarketRank

1.70 out of 5 stars

Transportation Sector

116th out of 173 stocks

Pharmaceutical Preparations Industry

456th out of 687 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
Cryoport logo

About Cryoport (NASDAQ:CYRX)

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.

CYRX Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CYRX
Employees
791
Year Founded
N/A

Company Calendar

Last Earnings
5/05/2022
Today
6/28/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$61.17
High Stock Price Forecast
$92.00
Low Stock Price Forecast
$41.00
Forecasted Upside/Downside
+103.3%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
6 Analysts

Profitability

Net Income
$-275.53 million
Net Margins
-128.78%
Pretax Margin
-128.33%

Debt

Sales & Book Value

Annual Sales
$222.61 million
Book Value
$13.64 per share

Miscellaneous

Free Float
44,587,000
Market Cap
$1.49 billion
Optionable
Optionable
Beta
1.29














Cryoport Frequently Asked Questions

Should I buy or sell Cryoport stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Cryoport stock.
View analyst ratings for Cryoport
or view top-rated stocks.

What is Cryoport's stock price forecast for 2022?

6 equities research analysts have issued 12-month price objectives for Cryoport's shares. Their CYRX stock forecasts range from $41.00 to $92.00. On average, they anticipate Cryoport's stock price to reach $61.17 in the next twelve months. This suggests a possible upside of 103.3% from the stock's current price.
View analysts' price targets for Cryoport
or view top-rated stocks among Wall Street analysts.

How has Cryoport's stock price performed in 2022?

Cryoport's stock was trading at $59.17 at the beginning of 2022. Since then, CYRX stock has decreased by 49.2% and is now trading at $30.08.
View the best growth stocks for 2022 here
.

When is Cryoport's next earnings date?

Cryoport is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Cryoport
.

How were Cryoport's earnings last quarter?

Cryoport, Inc. (NASDAQ:CYRX) released its earnings results on Thursday, May, 5th. The consumer goods maker reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by $0.11. The consumer goods maker had revenue of $52.30 million for the quarter, compared to analysts' expectations of $52.86 million. Cryoport had a negative trailing twelve-month return on equity of 13.79% and a negative net margin of 128.78%. The company's quarterly revenue was down 1.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.13) earnings per share.
View Cryoport's earnings history
.

What guidance has Cryoport issued on next quarter's earnings?

Cryoport updated its FY 2022 earnings guidance on Monday, May, 30th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $260.00 million-$265.00 million, compared to the consensus revenue estimate of $257.32 million.

Who are Cryoport's key executives?

Cryoport's management team includes the following people:
  • Mr. Jerrell W. Shelton, Chairman, Pres & CEO (Age 77, Pay $1.32M) (LinkedIn Profile)
  • Mr. Robert S. Stefanovich, Sr. VP, CFO, Treasurer & Corp. Sec. (Age 57, Pay $683.7k) (LinkedIn Profile)
  • Dr. Mark W. Sawicki Ph.D., Sr. VP & Chief Scientific Officer
  • Tony Ippolito, VP & Gen. Counsel
  • Mr. Thomas J. Heinzen, VP of Corp. Devel.
  • Mr. Bret Bollinger, Chief Technology Officer of Cryoport Systems, LLC (Age 55)
  • Mr. Phil Wilson, Chief Operating Officer of Cryoport Systems, LLC
  • Mr. Raymond Takahashi M.D., Exec. Officer
  • Mr. David Petreccia M.D., Exec. Officer

What other stocks do shareholders of Cryoport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Amarin (AMRN), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Pfizer (PFE) and Square (SQ).

What is Cryoport's stock symbol?

Cryoport trades on the NASDAQ under the ticker symbol "CYRX."

Who are Cryoport's major shareholders?

Cryoport's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (7.12%), Invesco Ltd. (6.54%), BlackRock Inc. (6.13%), Chevy Chase Trust Holdings Inc. (3.36%), Victory Capital Management Inc. (3.34%) and Clearbridge Investments LLC (2.45%). Company insiders that own Cryoport stock include Daniel M Hancock, Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman and Robert Stefanovich.
View institutional ownership trends for Cryoport
.

Which major investors are selling Cryoport stock?

CYRX stock was sold by a variety of institutional investors in the last quarter, including Handelsbanken Fonder AB, Chevy Chase Trust Holdings Inc., Granahan Investment Management LLC, Handelsinvest Investeringsforvaltning, PEAK6 Investments LLC, Redwood Investments LLC, Williams Jones Wealth Management LLC., and Bank of America Corp DE. Company insiders that have sold Cryoport company stock in the last two years include Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman, and Robert Stefanovich.
View insider buying and selling activity for Cryoport
or view top insider-selling stocks.

Which major investors are buying Cryoport stock?

CYRX stock was acquired by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Invesco Ltd., Renaissance Technologies LLC, Victory Capital Management Inc., Clearbridge Investments LLC, abrdn plc, Vanguard Group Inc., and State Street Corp.
View insider buying and selling activity for Cryoport
or or view top insider-buying stocks.

How do I buy shares of Cryoport?

Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cryoport's stock price today?

One share of CYRX stock can currently be purchased for approximately $30.08.

How much money does Cryoport make?

Cryoport (NASDAQ:CYRX) has a market capitalization of $1.49 billion and generates $222.61 million in revenue each year. The consumer goods maker earns $-275.53 million in net income (profit) each year or ($6.11) on an earnings per share basis.

How many employees does Cryoport have?

Cryoport employs 791 workers across the globe.

How can I contact Cryoport?

Cryoport's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The official website for Cryoport is www.cryoport.com. The consumer goods maker can be reached via phone at (949) 470-2300, via email at [email protected], or via fax at 949-470-2306.

This page (NASDAQ:CYRX) was last updated on 6/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.